Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Immunotherapies represent a promising strategy for glioblastoma multiforme (GBM) treatment. Different immunotherapies include the use of checkpoint inhibitors, adoptive cell therapies such as chimeric antigen receptor (CAR) T cells, and vaccines such as dendritic cell vaccines. Antibodies have also...

Full description

Bibliographic Details
Main Authors: Stefaan W. Van Gool, Jennifer Makalowski, Simon Fiore, Tobias Sprenger, Lothar Prix, Volker Schirrmacher, Wilfried Stuecker
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
GBM
newcastle disease virus
modulated electrohyperthermia
dendritic cell vaccination
clinical trial
individualized multimodal immunotherapy
Online Access:https://www.mdpi.com/2072-6694/13/1/32

Similar Items

Similar Items